Rockland, Massachusetts, November 17, 2017 – EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that it has been named to The Boston Globe’s annual “Top Places to Work” list for the second consecutive year.
EMD Serono submitted a joint nomination with MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany as the Massachusetts-based businesses of Merck KGaA, Darmstadt, Germany. Based on employee survey results, both were together named to the list of “Top Places to Work.”
“We’re honored to be recognized by The Boston Globe for the second year in a row, and grateful to our team of bold difference-makers who made it happen,” said Gary Zieziula, President and Managing Director, EMD Serono. “This distinction underscores the value of fostering innovation, collaboration and loyalty among our employees, who in turn are delivering meaningful solutions for patients.”
According to The Boston Globe, employers named to the “Top Places to Work” list share several key traits, including progressive benefit offerings, a culture of autonomy and inclusion, as well as an element of “fun” in the workplace.
“Top Places to Work” recognizes the best places to work in the state based on internal employee surveys. Award selection is based on anonymous employee surveys conducted by The Boston Globe’s research partner, Energage (formerly WorkplaceDynamics), from nearly 75,060 individuals at 334 Massachusetts organizations.
Employers who enter to be surveyed are placed into one of four groups: small, with 50 to 99 employees; midsize, with 100 to 249 workers; large, with 250 to 999; and largest, with 1,000 or more. In total, the Massachusetts-based businesses of Merck KGaA, Darmstadt, Germany employ approximately 2,500 team members across the area. Included in that number are roughly 100 EMD Performance Materials employees based in Haverhill, Mass., who also participated in this year’s survey.
All Merck KGaA, Darmstadt, Germany news releases are distributed by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please go to www.emdgroup.com/subscribe to register again for your online subscription of this service as our newly introduced geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About EMD Serono, Inc.
EMD Serono is the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada - a leading science and technology company - focused exclusively on specialty care. For more than 40 years, the business has integrated cutting-edge science, innovative products and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, as well as a robust pipeline of potential therapies in oncology, immuno-oncology and immunology as R&D focus areas. Today, the business has approximately 1,300 employees around the country with commercial, clinical and research operations based in the company’s home state of Massachusetts. www.emdserono.com
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck KGaA, Darmstadt, Germany, generated sales of € 15.0 billion in 66 countries.
Founded in 1668, Merck KGaA, Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck KGaA, Darmstadt, Germany, holds the global rights to the ”Merck” name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.